Effect of adjunctive tobramycin inhalation versus placebo on early clinical response in the treatment of ventilator-associated pneumonia: the VAPORISE randomized-controlled trial

Intensive Care Med. 2020 Mar;46(3):546-548. doi: 10.1007/s00134-019-05914-5. Epub 2020 Jan 23.

Authors

Jason Stokker¹, Mina Karami², Rogier Hoek¹, Diederik Gommers³, Menno van der Eerden⁴

Affiliations

¹ Department of Pulmonary Medicine, Erasmus MC, Rotterdam, The Netherlands.
² Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
³ Department of Intensive Care, Erasmus MC, Rotterdam, The Netherlands.
⁴ Department of Pulmonary Medicine, Erasmus MC, Rotterdam, The Netherlands. m.vandereerden@erasmusmc.nl.

No abstract available

Publication types

Letter
Randomized Controlled Trial

MeSH terms

Administration, Inhalation
Anti-Bacterial Agents / therapeutic use
Double-Blind Method
Humans
Pneumonia, Ventilator-Associated* / drug therapy
Pseudomonas Infections* / drug therapy
Tobramycin / therapeutic use
Treatment Outcome

Substances

Anti-Bacterial Agents
Tobramycin